Literature DB >> 9557654

Scaffold attachment region-mediated enhancement of retroviral vector expression in primary T cells.

M Agarwal1, T W Austin, F Morel, J Chen, E Böhnlein, I Plavec.   

Abstract

We have studied retroviral transgene expression in primary human lymphocytes. Our data demonstrate that transgene expression is high in activated primary CD4+ T cells but significantly decreased in mitotically quiescent cells. Incorporation of a DNA fragment from the scaffold attachment region (SAR) of the human beta interferon gene into the vector improved transgene expression, particularly in quiescent cells. The SAR element functioned in an orientation-dependent manner and enhanced expression of Moloney murine leukemia virus- and murine embryonic stem cell-based vectors. Clonal analysis of transduced T cells showed that the SAR sequence did not confer position-independent expression on a transgene but rather prevented the decrease of expression when cells became quiescent. The SAR sequence also enhanced transgene expression in T cells generated from retrovirally transduced CD34-enriched hematopoietic progenitor-stem cells in a SCID-hu thymus-liver mouse model. We have used the SAR-containing retroviral vector to express the RevM10 gene, a trans-dominant mutant of the human immunodeficiency virus type 1 (HIV-1) Rev gene. Compared to a standard retroviral vector, the SAR-containing vector was up to 2 orders of magnitude more efficient in inhibiting replication of the HIV-1 virus in infected CD4+ peripheral blood lymphocyte populations in vitro. This is the first demonstration that SAR elements can be used to improve retroviral vector expression in human primary T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9557654      PMCID: PMC109594          DOI: 10.1128/JVI.72.5.3720-3728.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA.

Authors:  J Colicelli; S P Goff
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function.

Authors:  M H Malim; S Böhnlein; J Hauber; B R Cullen
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

4.  Formal proof that different-size Lyt-2 polypeptides arise from differential splicing and post-transcriptional regulation.

Authors:  M Tagawa; H Nakauchi; L A Herzenberg; G P Nolan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector.

Authors:  B A Bunnell; M Metzger; E Byrne; R A Morgan; R E Donahue
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

6.  RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.

Authors:  M L Bonyhadi; K Moss; A Voytovich; J Auten; C Kalfoglou; I Plavec; S Forestell; L Su; E Böhnlein; H Kaneshima
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo.

Authors:  S K Jang; M V Davies; R J Kaufman; E Wimmer
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro.

Authors:  L Su; R Lee; M Bonyhadi; H Matsuzaki; S Forestell; S Escaich; E Böhnlein; H Kaneshima
Journal:  Blood       Date:  1997-04-01       Impact factor: 22.113

9.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

10.  Long-term human hematopoiesis in the SCID-hu mouse.

Authors:  R Namikawa; K N Weilbaecher; H Kaneshima; E J Yee; J M McCune
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  19 in total

1.  The cHS4 insulator increases the probability of retroviral expression at random chromosomal integration sites.

Authors:  S Rivella; J A Callegari; C May; C W Tan; M Sadelain
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Performance of genomic bordering elements at predefined genomic loci.

Authors:  Sandra Goetze; Alexandra Baer; Silke Winkelmann; Kristina Nehlsen; Jost Seibler; Karin Maass; Jürgen Bode
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  A system for Cre-regulated RNA interference in vivo.

Authors:  Patrick Stern; Sophie Astrof; Stefan J Erkeland; Joshua Schustak; Phillip A Sharp; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-08       Impact factor: 11.205

4.  Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus.

Authors:  R Berkowitz; H Ilves; W Y Lin; K Eckert; A Coward; S Tamaki; G Veres; I Plavec
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

5.  Expression of herpes simplex virus ICP47 and human cytomegalovirus US11 prevents recognition of transgene products by CD8(+) cytotoxic T lymphocytes.

Authors:  C Berger; S Xuereb; D C Johnson; K S Watanabe; H P Kiem; P D Greenberg; S R Riddell
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Human beta interferon scaffold attachment region inhibits de novo methylation and confers long-term, copy number-dependent expression to a retroviral vector.

Authors:  Q Dang; J Auten; I Plavec
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

7.  Variables affecting in vivo performance of high-capacity adenovirus vectors.

Authors:  Gudrun Schiedner; Sabine Hertel; Marion Johnston; Volker Biermann; Volker Dries; Stefan Kochanek
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Strategies to insulate lentiviral vector-expressed transgenes.

Authors:  Ali Ramezani; Robert G Hawley
Journal:  Methods Mol Biol       Date:  2010

9.  Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors.

Authors:  R J Parks; J L Bramson; Y Wan; C L Addison; F L Graham
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 10.  Gene therapy: design and prospects for craniofacial regeneration.

Authors:  E L Scheller; P H Krebsbach
Journal:  J Dent Res       Date:  2009-07       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.